A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Chemistry and Biology

• Publication date

  2006-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CHEMBIOL.2006.09.017PMID 17114004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor.

  2006cited by this paper
• Oral fingolimod (FTY720) for relapsing multiple sclerosis.

  2006cited by this paper
• Highly Selective and Potent Agonists of Sphingosine‐1‐phosphate 1 (S1P1) Receptor.

  2006cited by this paper
• Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3.

  2005cited by this paper
• FTY720, A Novel Immunomodulator: Efficacy and Safety Results from the First Phase 2A Study in de novo Renal Transplantation

  2005cited by this paper
• The Heart Rate Decrease Caused by Acute FTY720 Administration Is Mediated by the G Protein‐Gated Potassium Channel IKACh

  2005cited by this paper
• S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.

  2005influential reference
• Sphingosine Kinase 2 Is Required for Modulation of Lymphocyte Traffic by FTY720*

  2005cited by this paper
• Physiological sphingosine 1‐phosphate requirement for optimal activity of mouse CD4+25+ regulatory T Cells

  2004cited by this paper
• Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice.

  2004cited by this paper
• Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

  2004cited by this paper
• Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes

  2004cited by this paper
• FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.

  2004cited by this paper
• Expression of the Sphingosine 1-Phosphate Receptor, S1P1, on T-cells Controls Thymic Emigration*

  2004cited by this paper
• Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate*

  2004cited by this paper
• Transactivation of Sphingosine-1–Phosphate Receptors by FcɛRI Triggering Is Required for Normal Mast Cell Degranulation and Chemotaxis

  2004cited by this paper
• Sphingosine 1-Phosphate ( S 1 P ) Receptor Subtypes S 1 P 1 and S 1 P 3 , Respectively , Regulate Lymphocyte Recirculation and Heart Rate *

  2004cited by this paper
• Physiological and pathological actions of sphingosine 1-phosphate.

  2004cited by this paper
• FTY720: Sphingosine 1‐Phosphate Receptor‐1 in the Control of Lymphocyte Egress and Endothelial Barrier Function

  2004cited by this paper
• Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone

  2004cited by this paper
• Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonist

  2003cited by this paper
• Transduction of Multiple Effects of Sphingosine 1-Phosphate (S1P) on T Cell Functions by the S1P1 G Protein-Coupled Receptor 1

  2003cited by this paper
• Phosphorylation and Action of the Immunomodulator FTY720 Inhibits Vascular Endothelial Cell Growth Factor-induced Vascular Permeability*

  2003cited by this paper
• The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors*

  2002cited by this paper
• First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients.

  2002cited by this paper
• Molecular basis for lysophosphatidic acid receptor antagonist selectivity.

  2002cited by this paper
• FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity.

  2002cited by this paper
• Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

  2002cited by this paper
• A Single Amino Acid Determines Lysophospholipid Specificity of the S1P1 (EDG1) and LPA1 (EDG2) Phospholipid Growth Factor Receptors*

  2001cited by this paper
• FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression.

  2001cited by this paper
• FTY720: altered lymphocyte traffic results in allograft protection.

  2001cited by this paper
• Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.

  2001cited by this paper
• Crystal structure of rhodopsin: A G protein-coupled receptor.

  2000cited by this paper
• Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6.

  2000cited by this paper
• Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.

  2000cited by this paper
• FTY720 Immunosuppression Impairs Effector T Cell Peripheral Homing Without Affecting Induction, Expansion, and Memory1

  2000cited by this paper
• Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1.

  1998cited by this paper
• Development and validation of a genetic algorithm for flexible docking.

  1997cited by this paper
• Improved technique of heart transplantation in rats.

  1969cited by this paper

• Hepatoprotective, Nephroprotective and Hematoprotective Effects of the Mixture of Cissus polyantha Gilg & Brandt and Rytigynia senegalensis Blume in a Model of Type 2 Diabetes Mellitus

  2025cites this paper
• S1P receptor 1 antagonist ponesimod alleviates postherpetic neuralgia in rats by normalizing spinal TRPV1 expression and inhibiting MAPK-mediated glial activation

  2025cites this paper
• Extracorporeal photopheresis induces the release of anti-inflammatory fatty acids and oxylipins and suppresses pro-inflammatory sphingosine-1-phosphate

  2025cites this paper
• Role of S1PR1 in Modulating Airway Epithelial Responses to Pseudomonas aeruginosa in Cystic Fibrosis

  2025cites this paper
• Antidiabetic effect of the mixture of Cissus polyantha and Rytigynia senegalensis in high-fat diet and streptozocin-induced diabetic rats

  2024cites this paper
• Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis

  2024cites this paper
• Lysophospholipid (S1P) receptors in GtoPdb v.2023.1

  2023cites this paper
• The S1P receptor 1 antagonist Ponesimod reduces TLR4-induced neuroinflammation and increases Aβ clearance in 5XFAD mice

  2023cites this paper
• S1P/S1PR signaling pathway advancements in autoimmune diseases

  2023cites this paper
• Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis.

  2023cites this paper
• Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives

  2022cites this paper
• Repurposing the Sphingosine-1-Phosphate Receptor Modulator Etrasimod as an Antibacterial Agent Against Gram-Positive Bacteria

  2022cites this paper
• In vitro assessment of the binding and functional reponses of ozanimod and its plasma metabolites across human sphingosine 1-phosphate receptors.

  2022cites this paper
• Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5

  2021cites this paper
• Lysophospholipid (S1P) receptors in GtoPdb v.2021.2

  2021cites this paper
• A Glimpse of the Structural Biology of the Metabolism of Sphingosine-1-Phosphate

  2021cites this paper
• Does Siponimod Exert Direct Effects in the Central Nervous System?

  2020cites this paper
• Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis

  2020cites this paper
• Targeting the S1P receptor signaling pathways as a promising approach for treatment of autoimmune and inflammatory diseases.

  2020cites this paper
• The ceramide-S1P pathway as a druggable target to alleviate peripheral neuropathic pain

  2020cites this paper
• Lysophospholipid (S1P) receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• ASP1126, a Novel Sphingosine-1-Phosphate-Selective Agonist With a Favorable Safety Profile, Prolongs Allograft Survival in Rats and Nonhuman Primates in Combination With Tacrolimus With a Broad Safety Margin for Bradycardia.

  2019cites this paper
• S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy

  2019cites this paper
• Lysolipid receptor cross-talk regulates lymphatic endothelial junctions in lymph nodes

  2019cites this paper
• Lysophospholipid ( S 1 P ) receptors ( version 2019 . 4 ) in the IUPHAR / BPS Guide to Pharmacology Database

  2019cites this paper
• Matrine alleviates astrogliosis through sphingosine 1-phosphate signaling in experimental autoimmune encephalomyelitis.

  2019cites this paper
• Sphingosine-1-phosphate receptor 2 restrains egress of γδ T cells from the skin

  2019cites this paper
• An update on sphingosine-1-phosphate receptor 1 modulators.

  2018cites this paper
• The Xenopus tadpole: An in vivo model to screen drugs favoring remyelination

  2018cites this paper
• Heterotypic inter-GPCR ß-arrestin coupling regulates lymphatic endothelial junctional architecture in murine lymph nodes

  2018cites this paper
• Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism

  2017cites this paper
• Mast cell and eosinophil surface receptors as targets for anti‐allergic therapy

  2017cites this paper
• Effect of hypoxia on the cardiovascular sphingolipid system

  2017cites this paper
• A benzo[b]thiophene-based selective type 4 S1P receptor agonist.

  2017cites this paper
• Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?

  2017cites this paper
• Identification of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1) as a Pathogenic Factor in Transient Focal Cerebral Ischemia

  2017cites this paper
• Targeting sphingosine-1-phosphate signaling for cancer therapy

  2017cites this paper
• Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery

  2017cites this paper
• Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase).

  2016cites this paper
• Regulation of endothelial nitric oxide synthase activation in endothelial cells by S1P1 and S1P3.

  2016cites this paper
• Sphingosine 1-phosphate signaling in astrocytes: Implications for progressive multiple sclerosis.

  2016cites this paper
• Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors.

  2016cites this paper
• The role of sphingosine 1-phosphate in neutrophil trans-migration

  2016cites this paper
• Pharmacophore‐Based Design of Novel Oxadiazoles as Selective Sphingosine‐1‐phosphate (S1P) Receptor Agonists with in vivo Efficacy

  2015cites this paper
• Topical application of sphingosine 1-phosphate receptor 1 prolongs corneal graft survival in mice.

  2015cites this paper
• Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin

  2015cites this paper
• Review: novel insights into the regulation of vascular tone by sphingosine 1-phosphate.

  2014cites this paper
• Systemic application of sphingosine 1‐phosphate receptor 1 immunomodulator inhibits corneal allograft rejection in mice

  2014cites this paper
• Design, Synthesis, and Biological Evaluation of Sphingosine1-Phosphate Receptor (S1PR) Agonists

  2014cites this paper
• Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling.

  2014cites this paper
• Lysophospholipid receptor nomenclature review: IUPHAR Review 8

  2014influential citation
• An update on the biology of sphingosine 1-phosphate receptors

  2014cites this paper
• Role of sphingosine 1-phosphate in trafficking and mobilization of hematopoietic stem cells

  2013cites this paper
• Novel Sphingosine-1-Phosphate Receptor Modulator KRP203 Combined With Locally Delivered Regulatory T Cells Induces Permanent Acceptance of Pancreatic Islet Allografts

  2013cites this paper
• Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator.

  2013cites this paper
• The structure and function of the S1P1 receptor.

  2013cites this paper
• Sphingosine-1-phosphate: a Janus-faced mediator of fibrotic diseases.

  2013cites this paper
• S1P1 localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity

  2013cites this paper
• Pharmacology of the sphingosine-1-phosphate signalling system.

  2013cites this paper
• The Concise Guide to Pharmacology 2013/14: G Protein-Coupled Receptors

  2013cites this paper
• Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress.

  2013cites this paper
• Sphingosine-1-phosphate and its receptors: structure, signaling, and influence.

  2013cites this paper
• Sphingosine-1-Phosphate-Induced Airway Hyper-Reactivity in Rodents Is Mediated by the Sphingosine-1-Phosphate Type 3 Receptor

  2012cites this paper
• An oral sphingosine 1-phosphate receptor 1 (S1P(1)) antagonist prodrug with efficacy in vivo: discovery, synthesis, and evaluation.

  2012cites this paper
• Post-Transplant Immunosuppression: Regulation of the Efflux of Allospecific Effector T Cells from Lymphoid Tissues

  2012cites this paper
• Isoform-selective thiazolo[5,4-b]pyridine S1P1 agonists possessing acyclic amino carboxylate head-groups.

  2012cites this paper
• The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate

  2012cites this paper
• Sphingosine 1-phosphate as a therapeutic target in heart failure: more questions than answers.

  2012cites this paper
• Insights into the pharmacological relevance of lysophospholipid receptors

  2012cites this paper
• A Sphingosine-1-Phosphate Receptor 1-Directed Agonist Reduces Central Nervous System Inflammation in a Plasmacytoid Dendritic Cell-Dependent Manner

  2012cites this paper
• Sphingosine-1-phosphate signaling and its role in disease.

  2012cites this paper
• Treatment with a sphingosine-1-phosphate analog inhibits airway remodeling following repeated allergen exposure.

  2012cites this paper
• This information is current as Dendritic Cell-Dependent Manner System Inflammation in a Plasmacytoid 1-Directed Agonist Reduces Central Nervous A Sphingosine-1-Phosphate Receptor

  2012cites this paper
• Identification of benzoxazole analogs as novel, S1P(3) sparing S1P(1) agonists.

  2012cites this paper
• Significant Reduction of Acute Cardiac Allograft Rejection by Selective Janus Kinase-1/3 Inhibition Using R507 and R545

  2012cites this paper
• Sphingosine-1-phosphate signaling as a therapeutic target

  2012cites this paper
• exposureairway remodeling following repeated allergen Treatment with a sphingosine-1-phosphate analog

  2012cites this paper
• Translational aspects of sphingosine 1-phosphate biology.

  2011cites this paper
• 4-Methoxy-N-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: A Potent and Selective Agonist of S1P1.

  2011cites this paper
• Involvement of the sphingosine 1-phosphate receptor 3 in neuro-inflammation

  2011cites this paper
• Synthetic sphingosine 1-phosphate receptor modulators--opportunities and potential pitfalls.

  2011cites this paper
• Modulation of Chemokines and Allergic Airway Inflammation by Selective Local Sphingosine-1-phosphate Receptor 1 Agonism in Lungs

  2011cites this paper
• Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

  2011cites this paper
• Engagement of S1P₁-degradative mechanisms leads to vascular leak in mice.

  2011cites this paper
• The Selective Sphingosine 1-Phosphate Receptor 1 Agonist Ponesimod Protects against Lymphocyte-Mediated Tissue Inflammation

  2011cites this paper
• Fingolimod modulates microglial activation to augment markers of remyelination

  2011cites this paper
• Sphingosine Kinase 1 and Sphingosine 1-Phosphate Receptor 3 Are Functionally Upregulated on Astrocytes under Pro-Inflammatory Conditions

  2011cites this paper
• Guide to Receptors and Channels (GRAC), 5th edition

  2011cites this paper
• Pharmacological relevance and potential of sphingosine 1‐phosphate in the vascular system

  2011cites this paper
• Modulation of chemokines and allergic airway inflammation by selective local S1P1 agonism in lungs

  2010influential citation
• Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury.

  2010cites this paper
• Sphingosine-1-phosphate and its receptors as a possible therapeutic target in autoimmune diseases of the nervous system.

  2010cites this paper
• FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation

  2010cites this paper
• Pyrazole derived from (+)-3-carene; a novel potent, selective scaffold for sphingosine-1-phosphate (S1P(1)) receptor agonists.

  2010cites this paper
• Treatment with a sphingosine analog does not alter the outcome of a persistent virus infection.

  2010cites this paper
• S1P receptor mediated activity of FTY720 phosphate mimics.

  2010cites this paper
• Removal of sphingosine 1-phosphate receptor-3 (S1P(3)) agonism is essential, but inadequate to obtain immunomodulating 2-aminopropane-1,3-diol S1P(1) agonists with reduced effect on heart rate.

  2010cites this paper
• Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors

  2010cites this paper
• Elimination of a Hydroxyl Group in FTY720 Dramatically Improves the Phosphorylation Rate

  2010cites this paper
• Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics

  2010cites this paper